PATENT CLAIM ANALYSIS

Application Number: 15999239
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["424", "085400"]

Abstract:
Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks.

Claim (Index 20):
The method of  claim 19 , wherein the improved liver function is an improvement in one or more serum markers selected from the group consisting of serum albumin, bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), prothrombin, alfa2-macroglobulin, apolipoproteinA1, haptoglobin, gamma-glutamyl transpeptidase (GGT).

Metadata:
- Claim Count in Document: 52.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15335327', '13875253', '13119760', '15408087', '14449174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7697245199093212
- 35 USC 102 Novelty (BERT): 0.5342904485801995
- Combined Prediction Score: 0.7461811127764091
- Mean Citation Score: 274.69786200000004
- Max Citation Score: 376.35223
- Similarity Product: 217.4532361826741

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test